Highlights•COVID-19 vaccine development has accelerated at an incredible rate with 105
vaccines in clinical development and 18 approved for emergency use.•This is the first time in …

With the high rate of COVID-19 infections worldwide, the emergence of SARS-CoV-2
variants was inevitable. Several mutations have been identified in the SARS-CoV-2 …

Following the COVID-19 virus epidemic, extensive, coordinated international research has
led to the rapid development of effective vaccines. Although vaccines are now considered …

It has been more than three years since the first emergence of coronavirus disease 2019
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an emerging virus that
has caused the recent coronavirus disease (COVID-19) global pandemic. The current …

Abstract The SARS-CoV-2 Omicron subvariant BA. 5 rapidly spread worldwide and replaced
BA. 1/BA. 2 in many countries, becoming globally dominant. BA. 5 has unique amino acid …

Background Since the emergency use approval of different types of COVID-19 vaccines,
several safety concerns have been raised regarding its early and delayed impact on the …

We are currently approaching three years since the beginning of the coronavirus disease
2019 (COVID-19) pandemic. SARS-CoV-2 has caused extensive disruptions in everyday …

The novel mRNA vaccinations against COVID-19 are gaining worldwide attention for their
potential efficacy, as well as for the diagnosis of some post-vaccination-reported adverse …

Designing and producing an effective vaccine is the best possible way to reduce the burden
and spread of a disease. During the coronavirus disease 2019 (COVID-19) pandemic, many …